Acorah Software Products - Accounts Production 16.5.460 false true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 03145513 Mr Andrew Christophers Mr Thomas Ellis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 03145513 2023-12-31 03145513 2024-12-31 03145513 2024-01-01 2024-12-31 03145513 frs-core:CurrentFinancialInstruments 2024-12-31 03145513 frs-core:FurnitureFittings 2024-12-31 03145513 frs-core:FurnitureFittings 2024-01-01 2024-12-31 03145513 frs-core:FurnitureFittings 2023-12-31 03145513 frs-core:WithinOneYear 2024-12-31 03145513 frs-core:CapitalRedemptionReserve 2024-12-31 03145513 frs-core:ShareCapital 2024-12-31 03145513 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 03145513 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 03145513 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 03145513 frs-bus:SmallEntities 2024-01-01 2024-12-31 03145513 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 03145513 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 03145513 frs-core:CostValuation 2023-12-31 03145513 frs-core:AdditionsToInvestments 2024-12-31 03145513 frs-core:CostValuation 2024-12-31 03145513 frs-core:ProvisionsForImpairmentInvestments 2023-12-31 03145513 frs-core:ProvisionsForImpairmentInvestments 2024-12-31 03145513 frs-bus:Director1 2024-01-01 2024-12-31 03145513 frs-bus:Director2 2024-01-01 2024-12-31 03145513 frs-countries:EnglandWales 2024-01-01 2024-12-31 03145513 2022-12-31 03145513 2023-12-31 03145513 2023-01-01 2023-12-31 03145513 frs-core:CurrentFinancialInstruments 2023-12-31 03145513 frs-core:BetweenOneFiveYears 2023-12-31 03145513 frs-core:WithinOneYear 2023-12-31 03145513 frs-core:CapitalRedemptionReserve 2023-12-31 03145513 frs-core:ShareCapital 2023-12-31 03145513 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 03145513
Brand Genetics Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2024
Brand Genetics Ltd
Contents
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—7
Page 1
Brand Genetics Ltd
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 03145513
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 33,600 39,465
Investments 5 471 141
34,071 39,606
CURRENT ASSETS
Debtors 6 2,949,396 2,437,892
Cash at bank and in hand 848,993 1,106,482
3,798,389 3,544,374
Creditors: Amounts Falling Due Within One Year 7 (1,165,102 ) (1,129,400 )
NET CURRENT ASSETS (LIABILITIES) 2,633,287 2,414,974
TOTAL ASSETS LESS CURRENT LIABILITIES 2,667,358 2,454,580
PROVISIONS FOR LIABILITIES
Deferred Taxation (8,399 ) (9,282 )
NET ASSETS 2,658,959 2,445,298
CAPITAL AND RESERVES
Called up share capital 192 192
Capital redemption reserve 522 522
Profit and Loss Account 2,658,245 2,444,584
SHAREHOLDERS' FUNDS 2,658,959 2,445,298
Page 1
Page 2
Brand Genetics Ltd
Balance Sheet (continued)
As At 31 December 2024
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Thomas Ellis
Director
24 September 2025
The notes on pages 3 to 7 form part of these financial statements.
Page 2
Page 3
Brand Genetics Ltd
Notes to the Financial Statements
For The Year Ended 31 December 2024
Notes to the Financial Statements
1. General Information
Brand Genetics Ltd is a private company, limited by shares, incorporated in England & Wales, the registered number is 03145513 . The registered office is 24 Fitzroy Square, London, England, W1T 6EP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of value added taxes. Turnover is measured by reviewing the actual services performed against the total services to be provided and is only recognised if it can be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures and fittings 25% reducing balance
2.4. Leasing and Hire Purchase Contracts
Assets obtained under hire purchase contracts and finance leases are capitalised as tangible fixed assets. 
Assets acquired under hire purchase contracts are depreciated over their useful lives.
Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. 
Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.
2.5. Financial Instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at
transaction price including transaction costs and are subsequently carried at amortised cost using the
...CONTINUED
Page 3
Page 4
Brand Genetics Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
2.5. Financial Instruments - continued
effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual
arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. 
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. 
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
2.6. Foreign Currencies
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
Forward contracts are used to hedge against currency risk. Under FRS 102 S1A, forward contracts are initially measured at fair value on the date the contract is entered into and subsequently remeasured at fair value at each reporting date. Changes in the fair value of forward contracts that qualify as effective hedges of foreign currency exposure are recognized in other comprehensive income. Any ineffective portion of the hedge is recognized immediately in profit or loss. For forward contracts that do not qualify as hedges, changes in fair value are recognized directly in profit or loss.
2.7. Taxation
The taxation expense represents the sum of the tax currently payable and deferred tax. Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
...CONTINUED
Page 4
Page 5
Brand Genetics Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
2.7. Taxation - continued
Deferred tax 
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
2.8. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.9. Fixed Asset Investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and
subsequently measured at cost less any accumulated impairment losses. The investments are assessed for
impairment at each reporting date and any impairment losses or reversals of impairment losses are
recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a longterm interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement
are classified as jointly controlled entities.
2.10. Derivatives
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to
the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when
there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 29 (2023: 29)
29 29
Page 5
Page 6
Brand Genetics Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
4. Tangible Assets
Fixtures and fittings
£
Cost
As at 1 January 2024 237,511
Additions 6,519
Disposals (1,998 )
As at 31 December 2024 242,032
Depreciation
As at 1 January 2024 198,046
Provided during the period 10,386
As at 31 December 2024 208,432
Net Book Value
As at 31 December 2024 33,600
As at 1 January 2024 39,465
5. Investments
Subsidiaries
£
Cost
As at 1 January 2024 141
Additions 330
As at 31 December 2024 471
Provision
As at 1 January 2024 -
As at 31 December 2024 -
Net Book Value
As at 31 December 2024 471
As at 1 January 2024 141
Brand Generics Consultoria LTDA
The company holds 90% of Brand Generics Consultoria LTDA, a company registered in Brazil.
Profit for the year: £64,781
Capital and reserves: £194,829
Brand Genetics, Inc.
The company holds 100% of Brand Genetics, Inc., a company registered in the USA.
Profit/(Loss) for the year: (£57,858)
Capital and reserves: £39,542
Page 6
Page 7
Brand Genetics Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 2,450,880 2,100,114
Amounts owed by group undertakings 309,263 110,312
Other debtors 189,253 227,466
2,949,396 2,437,892
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 94,781 77,443
Other creditors 764,543 767,718
Taxation and social security 305,778 284,239
1,165,102 1,129,400
8. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
2024 2023
£ £
Not later than one year 17,680 70,720
Later than one year and not later than five years - 17,680
17,680 88,400
9. Related Party Transactions
At 31 December 2024, Brand Genetics, Inc. owed a balance of £783,779 to Brand Genetics Limited. Brand
Genetics Consultoria LTDA owed a balance of £15,247.
During the year, the company did not enter into any transactions with the 90% owned subsidiary, Brand Genetics Consultoria LTDA. There was no interest charged on the loan and outstanding balances are unsecured and will be settled in cash. No guarantees have been given or received. 
Page 7